ITP

Clinical trials for ITP explained in plain language.

Never miss a new study

Get alerted when new ITP trials appear

Sign up with your email to follow new studies for ITP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New hope for kids with Hard-to-Treat bleeding disorder

Disease control Not yet recruiting

This study tests a drug called romiplostim in 100 children aged 1 to 18 with chronic ITP, a condition where the immune system destroys platelets, causing bleeding. The drug aims to safely increase platelet counts to safe levels for at least 6 weeks out of 48, without needing resc…

Matched conditions: ITP

Sponsor: Assiut University • Aim: Disease control

Last updated May 18, 2026 12:08 UTC

ITP

Get alerted when new ITP trials appear

New hope for kids with Hard-to-Treat bleeding disorder